Pediatric patients with HS have an increased prevalence of chronic medical and psychiatric comorbidities.

Stigma around alopecia causes more depression and anxiety than the disease itself.

Biologic treatment of psoriasis can raise the risk of superficial fungal infections in patients, especially with IL-17 inhibitors.

Ivarmacitinib has been shown to be effective and safe in treating adolescent and adult patients with AD.

A novel oral nutraceutical may improve skin health and mild-to-moderate acne in women.

PanDerm, an AI model built specifically to assist with real-world dermatology practices, may benefit both dermatologists and clinicians in skin cancer diagnoses.

Teen skin-care routines shared by influencers on the social media platform TikTok offer no real benefit to pediatric populations and include ingredients that aggravate the skin.

More than one-third of psoriasis patients on biologics still have increased inflammatory markers in their blood.